CDK4/6 and CDK2 are the dominant CDKs that control cell G1/S transition though finely tuned regulation of the phosphorylation of the Rb cancer suppressor, which subsequently releases E2F, a transcriptional factor involved in cell cycle regulation [40, 41]. This evidence concerns the gene CDK2 and cancer.